Classification Of Leukemia Cells Research Articles

A2M-LEUK: attention-augmented algorithm for blood cancer detection in children

Leukemia is a malignancy that affects the blood and bone marrow. Its detection and classification are conventionally done through labor-intensive and specialized methods. The diagnosis of blood cancer in children is a critical task that requires high precision and accuracy. This study proposes a novel approach utilizing attention mechanism-based machine learning in conjunction with image processing techniques for the precise detection and classification of leukemia cells. The proposed attention-augmented algorithm for blood cancer detection in children (A2M-LEUK) is an innovative algorithm that leverages attention mechanisms to improve the detection of blood cancer in children. A2M-LEUK was evaluated on a dataset of blood cell images and achieved remarkable performance metrics: Precision = 99.97%, Recall = 100.00%, F1-score = 99.98%, and Accuracy = 99.98%. These results indicate the high accuracy and sensitivity of the proposed approach in identifying and categorizing leukemia, and its potential to reduce the workload of medical professionals and improve the diagnosis of leukemia. The proposed method provides a promising approach for accurate and efficient detection and classification of leukemia cells, which could potentially improve the diagnosis and treatment of leukemia. Overall, A2M-LEUK improves the diagnosis of leukemia in children and reduces the workload of medical professionals.

Identification and Staging of B-Cell Acute Lymphoblastic Leukemia Using Quantitative Phase Imaging and Machine Learning.

Identification and classification of leukemia cells in a rapid and label-free fashion is clinically challenging and thus presents a prime arena for implementing new diagnostic tools. Quantitative phase imaging, which maps optical path length delays introduced by the specimen, has been demonstrated to discern cellular phenotypes based on differential morphological attributes. Rapid acquisition capability and the availability of label-free images with high information content have enabled researchers to use machine learning (ML) to reveal latent features. We developed a set of ML classifiers, including convolutional neural networks, to discern healthy B cells from lymphoblasts and classify stages of B cell acute lymphoblastic leukemia. Here, we show that the average dry mass and volume of normal B cells are lower than those of cancerous cells and that these morphologic parameters increase further alongside disease progression. We find that the relaxed training requirements of a ML approach are conducive to the classification of cell type, with minimal space, training time, and memory requirements. Our findings pave the way for a larger study on clinical samples of acute lymphoblastic leukemia, with the overarching goal of its broader use in hematopathology, where the prospect of objective diagnoses with minimal sample preparation remains highly desirable.